Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hoda, Daanish  [Clear All Filters]
2024
Tang J, Jensen RR, Bryan B, Hoda D, Hunter BD. reduced Cytokine Release Syndrome and improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell Transplant. Transplant Cell Ther. 2024.
2023
Ford CD, Hoda D, Lopansri BK, Parra M, Sharma P, Asch J. An Algorithm Addressing the Problem of Overdiagnoses of Clostridioides difficile Infections in Hematopoietic Stem-Cell Transplant Recipients: Effects on CDI Rates and Patient Outcomes. Transplant Cell Ther. 2023.
Gordon LI, Liu FFei, Braverman J, Hoda D, Ghosh N, Hamadani M, Hildebrandt GC, Peng L, Guo S, Shi L, et al. Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study. Haematologica. 2023.
2022
Sehgal A, Hoda D, Riedell PA, Ghosh N, Hamadani M, Hildebrandt GC, Godwin JE, Reagan PM, Wagner-Johnston N, Essell J, et al. Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study. Lancet Oncol. 2022.
Ford CD, Hunter BD, Lopansri BK, Coombs J, Fernley T, Asch J, Hoda D. Transfer of Extended Spectrum Cephalosporin Resistant Enterobacteriaceae Among Patients on a HSCT Unit and the Value of Surveillance and Contact Isolation. Transplant Cell Ther. 2022.
2020
Ford CD, Lopansri BK, Coombs J, Webb BJ, Asch J, Hoda D. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?. Transpl Infect Dis. 2020:e13279.
2019
Jensen RR, Healy RM, Ford CD, Child B, Majers J, Draper B, Hasan Y, Hoda D. Amlodipine and Calcineurin Inhibitor Induced Nephrotoxicity Following Allogeneic Hematopoietic Stem Cell Transplant. Clin Transplant. 2019:e13633.
2018
Webb BJ, Harrington R, Schwartz J, Kammerer J, Spalding J, Lee E, Dodds B, Kaufusi S, Goodman BE, Firth SD, et al. The Clinical and Economic Impact of Cytomegalovirus Infection in Recipients of Hematopoietic Stem Cell Transplantation. Transpl Infect Dis. 2018:e12961.